Court won't stop hormone replacement lawsuits

Oct 12, 2010

(AP) -- The Supreme Court won't reconsider a decision to reinstate more than 100 lawsuits filed by women who claimed that hormone replacement therapy caused breast cancer.

The high court refused on Tuesday to hear an appeal from Wyeth LLC and other pharmaceutical companies.

The 8th U.S. Circuit Court of Appeals overturned a federal judge's decision to throw out many of the lawsuits.

The drug companies wanted the case in federal court, and said plaintiffs added unrelated local defendants to ensure it would stay in state court. A federal judge agreed, and dismissed many of the lawsuits. But the appeal court overturned that ruling, saying that it had not been proven that the women had done anything wrong.

The case is Wyeth LLC v. Kirkland, 10-222.

Explore further: Simulation-based training improves endoscopy execution

4 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Court Denies Vonage Bid for Patent Case Retrial

May 04, 2007

A U.S. appeals court denies a request by Internet phone company Vonage Holdings that it order a retrial in the patent infringement case brought against it by Verizon Communications.

Appeals court considers ban on stem cell research

Sep 27, 2010

(AP) -- The Obama administration has told an appeals court that a judge's order halting federal funding of stem cell research would result in destruction of valuable biological materials and set back taxpayer-funded work.

Court rules against Bush administration

Mar 20, 2006

A federal appeals court has overturned a clean-air regulation issued by the Bush administration, ruling in favor of environmental advocacy groups.

Recommended for you

Simulation-based training improves endoscopy execution

Oct 18, 2014

(HealthDay)—Simulation-based training (SBT) improves clinicians' performance of gastrointestinal endoscopy in both test settings and clinical practice, according to research published in the October issue ...

Data sharing in pharmaceutical industry shows progress

Oct 16, 2014

To enhance the transparency of clinical trials for new drugs, a number of pharmaceutical firms have begun sharing data with investigators outside their own companies. Brian L. Strom, chancellor of Rutgers Biomedical and Health ...

Swiss drug maker Roche posts flat 3Q sales

Oct 16, 2014

(AP)—Swiss drugmaker Roche Holding AG has reported "stable" or flat sales for the first nine months of 2013 but says the results show strong demand for its cancer drugs and emerging new products.

User comments : 0